Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Carbidopa,Etilevodopa,Entacapone
Therapeutic Area : Neurology
Study Phase : IND Enabling
Sponsor : Erik Selin
Deal Size : $17.0 million
Deal Type : Series A Financing
Details : Proceeds from the financing will enable Intrance to initiate pivotal U.S. clinical trials for the company’s lead product, Lecigon® (in the Nordic countries and European markets) for enteral infusion (light weight infusion pump) in advanced Parkinsonâ€...
Brand Name : Lecigon
Molecule Type : Small molecule
Upfront Cash : Undisclosed
January 04, 2022
Lead Product(s) : Carbidopa,Etilevodopa,Entacapone
Therapeutic Area : Neurology
Highest Development Status : IND Enabling
Sponsor : Erik Selin
Deal Size : $17.0 million
Deal Type : Series A Financing
LOOKING FOR A SUPPLIER?
Reset All
